E
BioNTech SE BNTX
$105.07 -$5.81-5.24% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 113.67% -5.54% -20.33% 40.44% -24.11%
Total Other Revenue -- -- -- -- --
Total Revenue 113.67% -5.54% -20.33% 40.44% -24.11%
Cost of Revenue 34.71% 37.45% 34.62% 11.68% -63.70%
Gross Profit 182.20% -25.32% -27.90% 46.78% 1,319.37%
SG&A Expenses -21.18% -11.83% -8.08% -0.97% 31.80%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -110.21% -502.15% 110.26% 1,070.59% 1,599.24%
Total Operating Expenses -32.56% -4.96% 115.70% 46.66% 64.15%
Operating Income 52.12% 4.74% -84.39% -59.71% -94.41%
Income Before Tax 47.30% -30.13% -55.03% -29.51% -93.30%
Income Tax Expenses -948.81% -71.82% -79.89% -159.58% 100.89%
Earnings from Continuing Operations 49.54% -27.92% -43.89% 24.59% -319.53%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 49.54% -27.92% -43.89% 24.59% -319.53%
EBIT 52.12% 4.74% -84.39% -59.71% -94.41%
EBITDA 55.40% 5.81% -73.48% -29.61% -97.18%
EPS Basic 49.79% -28.02% -44.02% 23.63% -320.57%
Normalized Basic EPS 49.25% -31.04% -51.71% -13.95% -89.91%
EPS Diluted 49.79% -28.02% -43.76% 23.96% -320.57%
Normalized Diluted EPS 49.25% -31.04% -51.45% -13.71% -89.91%
Average Basic Shares Outstanding 0.50% -0.08% 0.23% 0.79% -0.25%
Average Diluted Shares Outstanding 0.50% -0.08% -0.30% 0.51% -0.25%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --